Ramipril Patent Invalid Due To Obviousness: Court
By Brendan Pierson · September 11, 2007, 12:00 AM EDT
An appeals court ruled on Tuesday that King Pharmaceutical's patent on its hypertension drug Altace was obvious and thus invalid, overturning a lower court's ruling that generics maker Lupin LTD infringed...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login